Close

Ratings by BofA Securities (Lyanne Harrison)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/20/2022 ResMed RMD Upgrade Buy
(Neutral)
215.30
(221.32)
2.8% Details
7/25/2022 ResMed RMD Maintain Neutral
(N/A)
 
 
  Details
6/15/2022 ResMed RMD Maintain Neutral
(N/A)
 
 
  Details
4/29/2022 ResMed RMD Maintain Neutral
(N/A)
 
 
  Details
1/24/2022 ResMed RMD Upgrade Neutral
(Underperform)
235.16
(221.32)
-5.89% Details
10/29/2021 ResMed RMD Maintain Underperform
(N/A)
 
 
  Details
10/26/2021 ResMed RMD Maintain Underperform
(N/A)
 
 
  Details
8/27/2021 Avita Medical Ltd. RCEL Maintain Buy
(N/A)
 
 
  Details
8/6/2021 ResMed RMD Maintain Underperform
(N/A)
 
 
  Details
6/24/2021 Avita Medical Ltd. RCEL Maintain Buy
(N/A)
 
 
  Details
6/16/2021 ResMed RMD Downgrade Underperform
(Neutral)
236.46
(221.32)
-6.4% Details
8/3/2020 ResMed RMD Downgrade Neutral
(Buy)
202.51
(236.46)
16.76% Details
10/25/2019 ResMed RMD Maintain Buy
(N/A)
 
 
  Details